12 Results for "

FGFR3-IN-4

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "FGFR3-IN-4" in MCE Product Catalog:

Cat. No.: HY-148778
CAS No.: 2833706-13-9
Target:  

FGFR

Research Areas:  

Cancer

FGFR3-IN-4 is a selective FGFR3 inhibitor, with an IC50 value of less than 50 nM. FGFR3-IN-4 is at least 10 fold more selective for FGFR3 than for FGFR1 .
loading...
    loading...
22
22 Publications Verification
Cat. No.: HY-109099
CAS No.: 1513857-77-6
Purity:  99.84%
Synonyms: INCB054828
Target:  

FGFR

Research Areas:  

Cancer

Pemigatinib (INCB054828) is an orally active, selective FGFR inhibitor with IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-13304
CAS No.: 1254473-64-7
Purity:  99.14%
Target:  

FGFR

Research Areas:  

Cancer

LY2874455 is a pan-FGFR inhibitor with IC50s of 2.8, 2.6, 6.4, 6 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101768
CAS No.: 1802929-43-6
Purity:  99.78%
Target:  

FGFR c-Fms

Research Areas:  

Cancer

PRN1371 is a highly selective and potent FGFR1-4 and CSF1R inhibitor with IC50s of 0.6, 1.3, 4.1, 19.3 and 8.1 nM for FGFR1, FGFR2, FGFR3, FGFR4 and CSF1R, respectively .
loading...
    loading...
Cat. No.: HY-101466
CAS No.: 1622204-21-0
Purity:  99.64%
Target:  

FGFR

Research Areas:  

Cancer

E7090 is an orally available, potent, and selective FGFR inhibitor with IC50s of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/FGFR2/FGFR3/FGFR4, respectively .
loading...
    loading...
Cat. No.: HY-152146
CAS No.: 2653339-26-3
Target:  

Apoptosis FGFR HDAC

Research Areas:  

Cancer

HDAC-IN-50 is a potent and orally active FGFR and HDAC dual inhibitor with IC50 values of 0.18, 1.2, 0.46, 1.4, 1.3, 1.6, 2.6, 13 nM for FGFR1, FGFR2, FGFR3, FGFR4, HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-50 induces Apoptosis and cell cycle arrest at G0/G1 phase. HDAC-IN-50 decreases the expression of pFGFR1, pERK, pSTAT3. HDAC-IN-50 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-152104
CAS No.: 3024090-08-9
Target:  

FGFR

Research Areas:  

Cancer

FGFR-IN-9 (Compound 19) is a potent, reversible and orally active FGFR inhibitor with an IC50 of 17.1, 29.6, 30.7, 46.7 and 64.3 nM against FGFR4 WT, FGFR3, FGFR4 V550L, FGFR2 and FGFR1, respectively .
loading...
    loading...
Cat. No.: HY-109099R
CAS No.: 1513857-77-6
Synonyms: INCB054828 (Standard)
Research Areas:  

Cancer

Pemigatinib (Standard) is the analytical standard of Pemigatinib. This product is intended for research and analytical applications. Pemigatinib (INCB054828) is an orally active, selective FGFR inhibitor with IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma .
loading...
    loading...
Cat. No.: HY-W754878
CAS No.: 2649492-49-7
Synonyms: INCB054828-d6
Pemigatinib-d6 (INCB054828-d6) is deuterium labeled Pemigatinib. Pemigatinib (INCB054828) is an orally active, selective FGFR inhibitor with IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma .
loading...
    loading...
Cat. No.: HY-101466R
CAS No.: 1622204-21-0
Research Areas:  

Cancer

E7090 (Standard) is the analytical standard of E7090 (HY-101466). This product is intended for research and analytical applications. E7090 is an orally available, potent, and selective FGFR inhibitor with IC50s of 0.71 nM, 0.50 nM, 1.2 nM, and 120 nM for FGFR1/FGFR2/FGFR3/FGFR4, respectively .
loading...
    loading...
Cat. No.: HY-101768R
CAS No.: 1802929-43-6
Research Areas:  

Cancer

PRN1371 (Standard) is the analytical standard of PRN1371 (HY-101768). This product is intended for research and analytical applications. PRN1371 is a highly selective and potent FGFR1-4 and CSF1R inhibitor with IC50s of 0.6, 1.3, 4.1, 19.3 and 8.1 nM for FGFR1, FGFR2, FGFR3, FGFR4 and CSF1R, respectively .
loading...
    loading...
Cat. No.: HY-184598
Research Areas:  

Cancer

CYB-5067 is a FGFR molecular glue degrader with a DC50 of 27 nM against FGFR2. CYB-5067 inhibits FGFR1, FGFR3, FGFR4 and downstream FGFR signaling pathways, induces antiproliferative activity in vitro, and exhibits sustained target protein inhibition in vivo without obvious hook effect. CYB-5067 shows significant tumor growth inhibitory activity in the ETV6-FGFR2 fusion Ba/F3 xenograft model. CYB-5067 can be used for the research of FGFR-driven cancers .
loading...
    loading...
  • 1